AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

NOXOPHARM LTD

0.075

-0.005-6.25%

Volume:44.52K

Turnover:3.48K

Market Cap:21.92M

PE:-4.49

High:0.079

Open:0.079

Low:0.075

Close:0.080

52wk High:0.135

52wk Low:0.043

Shares:292.24M

Float Shares:195.51M

Volume Ratio:0.06

T/O Rate:0.02%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.017

EPS(LYR):-0.017

ROE:-157.93%

ROA:-59.24%

PB:31.77

PE(LYR):-4.49

Loading ...

Overview Company News Filings

Concept

Novel Coronavirus Treatment-2.29%

Pharmaceutical Companies-4.89%

Capital Flow

Inflow:

Outflow:

News

We Think Noxopharm (ASX:NOX) Has A Fair Chunk Of Debt

Simply Wall St.

BUZZ-Australia's Noxopharm hits two-week high on autoimmune clinical trial progress

Noxopharm Ltd-Heracles Clinical Trial Update 5

THOMSON REUTERS

ASX Small-Cap Stocks to Watch

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/NOX.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NOX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"NOX.AU\",,,,,undefined,":{"symbol":"NOX.AU","market":"AU","secType":"STK","nameCN":"NOXOPHARM LTD","latestPrice":0.075,"timestamp":1770869343897,"preClose":0.08,"halted":0,"volume":44518,"delay":0,"changeRate":-0.06250000000000006,"nameEN":"NOXOPHARM LTD","floatShares":195506720,"shares":292237950,"eps":-0.016712,"marketStatus":"Pre CSPA","change":-0.005,"latestTime":"02-12 16:00:03 AEDT","open":0.079,"high":0.079,"low":0.075,"amount":3480,"amplitude":0.05,"askPrice":0.078,"askSize":46246,"bidPrice":0.075,"bidSize":98245,"shortable":3,"etf":0,"ttmEps":-0.016712,"tradingStatus":3,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1770937200000},"marketStatusCode":13,"adr":0,"exchange":"ASX","adjPreClose":0.08,"openAndCloseTimeList":[[1770850800000,1770872400000]],"volumeRatio":0.057651,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"NOX.AU\",,,,,undefined,":{"symbol":"NOX.AU","floatShares":195506720,"roa":"-59.24%","roe":"-157.93%","lyrEps":-0.016712,"volumeRatio":0.057651,"shares":292237950,"dividePrice":0,"high":0.079,"amplitude":0.05,"preClose":0.08,"low":0.075,"week52Low":0.043,"pbRate":"31.77","psRate":"7.77","week52High":0.135,"institutionHeld":0,"latestPrice":0.075,"committee":0.359877,"eps":-0.016712,"divideRate":0,"volume":44518,"delay":0,"ttmEps":-0.016712,"open":0.079,"prevYearClose":0.093,"prevWeekClose":0.059,"prevMonthClose":0.077,"prevQuarterClose":0.093,"fiveDayClose":0.067,"twentyDayClose":0.088,"sixtyDayClose":0.09,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NOX.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NOX.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NOX.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2589585176","title":"We Think Noxopharm (ASX:NOX) Has A Fair Chunk Of Debt","url":"https://stock-news.laohu8.com/highlight/detail?id=2589585176","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589585176?lang=en_us&edition=fundamental","pubTime":"2025-12-05 05:38","pubTimestamp":1764884290,"startTime":"0","endTime":"0","summary":"The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-nox/noxopharm-shares/news/we-think-noxopharm-asxnox-has-a-fair-chunk-of-debt","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-nox/noxopharm-shares/news/we-think-noxopharm-asxnox-has-a-fair-chunk-of-debt","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["EBIT","BK7501","BK7067","BK7508","NOX.AU"],"gpt_icon":0},{"id":"2588099272","title":"BUZZ-Australia's Noxopharm hits two-week high on autoimmune clinical trial progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2588099272","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588099272?lang=en_us&edition=fundamental","pubTime":"2025-12-03 11:39","pubTimestamp":1764733183,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Noxopharm hits two-week high on autoimmune clinical trial progress** Shares of Australia's Noxopharm NOX.AX rise 2.1% to A$0.099, their highest level since November 17** The biotechnology company says the first multiple-dose cohort in the in-human trial for co's autoimmune diseases drug, SOF-SKN, has been successfully completed, bringing co to the final second and final stage of the trial ** Safety Steering Committee has determined the treatment to be safe and well tolerated, with no clinically relevant issues found, co adds** Stock up 6.5%, YTD   ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251203:nL6N3X907R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NOX.AU","BK7508","BK7067","BK7501"],"gpt_icon":0},{"id":"2588066025","title":"Noxopharm Ltd-Heracles Clinical Trial Update 5","url":"https://stock-news.laohu8.com/highlight/detail?id=2588066025","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588066025?lang=en_us&edition=fundamental","pubTime":"2025-12-03 05:21","pubTimestamp":1764710499,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251202:nTUE4KLTYP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","BK7508","BK7501","NOX.AU"],"gpt_icon":0},{"id":"2584691997","title":"ASX Small-Cap Stocks to Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2584691997","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584691997?lang=en_us&edition=fundamental","pubTime":"2025-11-17 07:48","pubTimestamp":1763336888,"startTime":"0","endTime":"0","summary":"Investors are likely to keep an eye on the following small-cap stocks listed on the Australian Securities Exchange.Canadian Phosphate (ASX:CP8)Canadian Phosphate welcomed a decision by the US Departme","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7142","BK7504","BK7095","NGY.AU","BK7507","CP8.AU","BK7501","BK7067","NOX.AU","BK7508","BK7506","BK7020","BPM.AU","NMT.AU"],"gpt_icon":0}],"pageSize":4,"totalPage":4,"pageCount":1,"totalSize":16,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/NOX.AU\",params:#limit:6,delay:true,,,undefined,":[{"market":"AU","name":"Novel Coronavirus Treatment","bkCode":"BK7501","id":"package_au_concept_xgzlg","changeRate":-0.022893},{"market":"AU","name":"Pharmaceutical Companies","bkCode":"BK7508","id":"package_au_concept_yyswg","changeRate":-0.048875}]}}